MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

Trailbreaker Expands Footprint of High-Grade Gold Structure at Atsutla Gold Project, BC

Trailbreaker Resources Ltd. (TBK.V) ("Trailbreaker" or "the Company") is pleased to announce results from its 2025 ...